Regulation of retinoid X receptor responsive element-dependent transcription in T lymphocytes by Ser/Thr phosphatases: functional divergence of protein kinase C (PKC)theta; and PKC alpha in mediating calcineurin-induced transactivation

J Immunol. 2002 Jul 15;169(2):732-8. doi: 10.4049/jimmunol.169.2.732.

Abstract

T lymphocyte activation signals regulate the expression and transactivation function of retinoid X receptor (RXR) alpha through an interplay of complex signaling cascades that are not yet fully understood. We show that cellular Ser/Thr protein phosphatases (PPs) play an important role in mediating these processes. Inhibitors specific for PP1 and PP2A decreased basal expression of RXR alpha RNA and protein in T lymphocyte leukemia Jurkat cells and prevented activation-induced RXR alpha accumulation in these cells. In addition, these inhibitors attenuated the RXR responsive element (RXRE)-dependent transcriptional activation in transient transfection assays. Inhibitors of calcineurin (CN), by contrast, did not have any effect on the basal RXR alpha expression and even augmented activation-induced RXR alpha expression. Expression of a dominant-active (DA) mutant of CN together with a DA mutant of protein kinase C (PKC)theta;, a novel PKC isoform, significantly increased RXRE-dependent transcription. Expression of catalytically inactive PKC theta; or a dominant-negative mutant of PKC theta; failed to synergize with CN and did not increase RXRE-dependent transcription. Expression of a DA mutant of PKC alpha or treatment with PMA was found to attenuate PKC theta; and CN synergism. We conclude that PP1, PP2A, and CN regulate levels and transcriptional activation function of RXR alpha in T cells. In addition, CN synergizes with PKC theta; to induce RXRE-dependent activation, a cooperative function that is antagonized by the activation of the conventional PKC alpha isoform. Thus, PKC theta; and PKC alpha may function as positive and negative modulators, respectively, of CN-regulated RXRE-dependent transcription during T cell activation.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Calcineurin / metabolism*
  • Calcineurin / physiology
  • Calcineurin Inhibitors
  • Drug Synergism
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Isoenzymes / antagonists & inhibitors
  • Isoenzymes / physiology*
  • Jurkat Cells
  • Okadaic Acid / pharmacology
  • Phosphoprotein Phosphatases / antagonists & inhibitors
  • Phosphoprotein Phosphatases / physiology*
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / physiology*
  • Protein Kinase C-alpha
  • Protein Kinase C-theta
  • Protein Phosphatase 1
  • Receptors, Retinoic Acid / genetics*
  • Receptors, Retinoic Acid / metabolism
  • Response Elements / drug effects
  • Response Elements / immunology*
  • Retinoid X Receptors
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / enzymology
  • T-Lymphocytes / metabolism*
  • Tetradecanoylphorbol Acetate / pharmacology
  • Transcription Factors / genetics*
  • Transcription Factors / metabolism
  • Transcription, Genetic / drug effects
  • Transcription, Genetic / immunology*
  • Transcriptional Activation / drug effects
  • Transcriptional Activation / immunology*

Substances

  • Calcineurin Inhibitors
  • Enzyme Inhibitors
  • Isoenzymes
  • Receptors, Retinoic Acid
  • Retinoid X Receptors
  • Transcription Factors
  • Okadaic Acid
  • PRKCA protein, human
  • PRKCQ protein, human
  • Protein Kinase C
  • Protein Kinase C-alpha
  • Protein Kinase C-theta
  • Calcineurin
  • Phosphoprotein Phosphatases
  • Protein Phosphatase 1
  • Tetradecanoylphorbol Acetate